Medical Properties Trust (NYSE:MPW) Price Target Lowered to $4.00 at Truist Financial

Medical Properties Trust (NYSE:MPW) had its price target dropped by Truist Financial from $6.00 to $4.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s target price would indicate a potential upside of 3.63% from the stock’s current price.

MPW has been the subject of several other research reports. Wolfe Research raised shares of Medical Properties Trust to a “hold” rating in a research note on Monday, September 23rd. Mizuho lowered their price objective on shares of Medical Properties Trust from $6.00 to $5.00 and set a “neutral” rating for the company in a research report on Thursday, December 5th. Finally, Colliers Securities upgraded Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 target price on the stock in a report on Friday, September 13th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $4.92.

Medical Properties Trust Stock Performance

Shares of MPW stock opened at $3.86 on Thursday. The stock has a market cap of $2.32 billion, a PE ratio of -0.91, a price-to-earnings-growth ratio of 0.62 and a beta of 1.29. The stock has a 50-day moving average of $4.39 and a 200-day moving average of $4.77. The company has a debt-to-equity ratio of 1.69, a current ratio of 2.38 and a quick ratio of 2.38. Medical Properties Trust has a one year low of $2.92 and a one year high of $6.55.

Insiders Place Their Bets

In other Medical Properties Trust news, Director Michael G. Stewart sold 32,780 shares of the business’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $5.46, for a total value of $178,978.80. Following the sale, the director now owns 221,245 shares in the company, valued at approximately $1,207,997.70. The trade was a 12.90 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.53% of the company’s stock.

Institutional Trading of Medical Properties Trust

Hedge funds and other institutional investors have recently made changes to their positions in the business. Quadrature Capital Ltd bought a new position in Medical Properties Trust in the third quarter valued at $927,000. Wolverine Asset Management LLC grew its holdings in shares of Medical Properties Trust by 27.8% in the 3rd quarter. Wolverine Asset Management LLC now owns 517,866 shares of the real estate investment trust’s stock valued at $3,030,000 after acquiring an additional 112,721 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Medical Properties Trust by 353.5% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,525,714 shares of the real estate investment trust’s stock valued at $20,625,000 after acquiring an additional 2,748,245 shares during the last quarter. Thrivent Financial for Lutherans raised its holdings in Medical Properties Trust by 22.1% during the second quarter. Thrivent Financial for Lutherans now owns 793,003 shares of the real estate investment trust’s stock worth $3,418,000 after acquiring an additional 143,309 shares in the last quarter. Finally, Kestra Investment Management LLC acquired a new position in Medical Properties Trust during the third quarter valued at approximately $883,000. 71.79% of the stock is currently owned by institutional investors and hedge funds.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.